Cargando…

A Single-Cell Atlas of Tumor-Infiltrating Immune Cells in Pancreatic Ductal Adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies with limited treatment options. To guide the design of more effective immunotherapy strategies, mass cytometry was employed to characterize the cellular composition of the PDAC-infiltrating immune cells. The expression of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Hao, Chen, Lu, Qi, Lisha, Jiang, Na, Zhang, Zhibin, Guo, Hua, Song, Tianqiang, Li, Jun, Li, Hongle, Zhang, Ning, Chen, Ruibing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Biochemistry and Molecular Biology 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294203/ https://www.ncbi.nlm.nih.gov/pubmed/35718340 http://dx.doi.org/10.1016/j.mcpro.2022.100258

Ejemplares similares

The landscape of immune cell infiltration and its clinical implications of pancreatic ductal adenocarcinoma
por: Xu, Caiming, et al.
Publicado: (2020)

Association of Pancreatic Fatty Infiltration With Pancreatic Ductal Adenocarcinoma
por: Hori, Mika, et al.
Publicado: (2014)

The PD-L1 Expression and Tumor-Infiltrating Immune Cells Predict an Unfavorable Prognosis in Pancreatic Ductal Adenocarcinoma and Adenosquamous Carcinoma
por: Zhang, Zhiwei, et al.
Publicado: (2023)

Relevance of Immune Infiltration and Clinical Outcomes in Pancreatic Ductal Adenocarcinoma Subtypes
por: Liu, Rong, et al.
Publicado: (2021)

Surgical and local treatment of hepatic metastasis in pancreatic ductal adenocarcinoma: recent advances and future prospects
por: Jin, Tianqiang, et al.
Publicado: (2020)

Tumor-Infiltrating Immune Cell Signature Predicts the Prognosis and Chemosensitivity of Patients With Pancreatic Ductal Adenocarcinoma
por: Gao, Yuzhen, et al.
Publicado: (2020)

XGBoost Classifier Based on Computed Tomography Radiomics for Prediction of Tumor-Infiltrating CD8(+) T-Cells in Patients With Pancreatic Ductal Adenocarcinoma
por: Li, Jing, et al.
Publicado: (2021)

An Increased Abundance of Tumor-Infiltrating Regulatory T Cells Is Correlated with the Progression and Prognosis of Pancreatic Ductal Adenocarcinoma
por: Tang, Yichen, et al.
Publicado: (2014)

Clinical Significance of Tumor-Infiltrating Conventional and Plasmacytoid Dendritic Cells in Pancreatic Ductal Adenocarcinoma
por: Plesca, Ioana, et al.
Publicado: (2022)

Up-Regulated MISP Is Associated With Poor Prognosis and Immune Infiltration in Pancreatic Ductal Adenocarcinoma
por: Huang, Xinyang, et al.
Publicado: (2022)

CXCL5 overexpression predicts a poor prognosis in pancreatic ductal adenocarcinoma and is correlated with immune cell infiltration
por: Zhang, Ronghua, et al.
Publicado: (2020)

DKK2 Impairs Tumor Immunity Infiltration and Correlates with Poor Prognosis in Pancreatic Ductal Adenocarcinoma
por: Yang, Jianyu, et al.
Publicado: (2019)

Mast cells in pancreatic ductal adenocarcinoma
por: Chang, David Z.
Publicado: (2012)

Prognostic Implications of Intratumoral and Peritumoral Infiltrating Lymphocytes in Pancreatic Ductal Adenocarcinoma
por: Pyo, Jung-Soo, et al.
Publicado: (2021)

A case of pancreatic ductal adenocarcinoma with marked infiltration with IgG4-positive cells
por: Yoneda, M, et al.
Publicado: (2013)

Phenotype, function and T cell receptor repertoire of tumor-infiltrating lymphocytes in patients with pancreatic ductal adenocarcinoma
por: Poschke, Isabel, et al.
Publicado: (2015)

Identification of Key Prognostic Biomarker and Its Correlation with Immune Infiltrates in Pancreatic Ductal Adenocarcinoma
por: Luan, Hong, et al.
Publicado: (2020)

Comprehensive analysis of LILR family genes expression and tumour‐infiltrating immune cells in early‐stage pancreatic ductal adenocarcinoma
por: Gao, Qiang, et al.
Publicado: (2023)

Prognostic-Related Biomarkers in Pancreatic Ductal Adenocarcinoma Correlating with Immune Infiltrates Based on Proteomics
por: Kou, Yan-qi, et al.
Publicado: (2023)

Prognostic Stratification Based on HIF-1 Signaling for Evaluating Hypoxic Status and Immune Infiltration in Pancreatic Ductal Adenocarcinomas
por: Zhuang, Hongkai, et al.
Publicado: (2021)

Identification of solute carrier family genes related to the prognosis and tumor-infiltrating immune cells of pancreatic ductal adenocarcinoma
por: Meng, Yuhua, et al.
Publicado: (2022)

Comprehensive Analysis of Expression, Prognostic Value, and Immune Infiltration for Ubiquitination-Related FBXOs in Pancreatic Ductal Adenocarcinoma
por: Zhang, Yalu, et al.
Publicado: (2022)

Intra-tumoral infiltration of adipocyte facilitates the activation of antitumor immune response in pancreatic ductal adenocarcinoma
por: Liu, Xiaomeng, et al.
Publicado: (2022)

BAG3‐positive pancreatic stellate cells promote migration and invasion of pancreatic ductal adenocarcinoma
por: Yuan, Ye, et al.
Publicado: (2019)

Comparative Characterization of Stroma Cells and Ductal Epithelium in Chronic Pancreatitis and Pancreatic Ductal Adenocarcinoma
por: Helm, Ole, et al.
Publicado: (2014)

Pancreatic Ductal Adenocarcinoma Contains an Effector and Regulatory Immune Cell Infiltrate that Is Altered by Multimodal Neoadjuvant Treatment
por: Shibuya, Kendall C., et al.
Publicado: (2014)

Immune cell infiltrates as prognostic biomarkers in pancreatic ductal adenocarcinoma: a systematic review and meta‐analysis
por: McGuigan, Andrew J, et al.
Publicado: (2021)

Targeting dendritic cells in pancreatic ductal adenocarcinoma
por: Deicher, Anton, et al.
Publicado: (2018)

Cancer Stem Cells in Pancreatic Ductal Adenocarcinoma
por: Bubin, Roman, et al.
Publicado: (2023)

Oral mycobiota and pancreatic ductal adenocarcinoma
por: Wei, Ailin, et al.
Publicado: (2022)

The value of enhanced CT features and texture-signatures in assessing the inflammatory infiltration of pancreatic ductal adenocarcinoma
por: Wang, Fangqing, et al.
Publicado: (2023)

Proteome alterations in pancreatic ductal adenocarcinoma
por: Pan, Sheng, et al.
Publicado: (2020)

Interventional Nanotheranostics of Pancreatic Ductal Adenocarcinoma
por: Li, Junjie, et al.
Publicado: (2016)

The immune escape signature predicts the prognosis and immunotherapy sensitivity for pancreatic ductal adenocarcinoma
por: Lu, Hao, et al.
Publicado: (2022)

MRGBP as a potential biomarker for the malignancy of pancreatic ductal adenocarcinoma
por: Ding, Feng, et al.
Publicado: (2017)

SCF, Regulated by HIF-1α, Promotes Pancreatic Ductal Adenocarcinoma Cell Progression
por: Gao, Chuntao, et al.
Publicado: (2015)

The Role of Stellate Cells in Pancreatic Ductal Adenocarcinoma: Targeting Perspectives
por: Wu, Yang, et al.
Publicado: (2021)

Tsoong induces apoptosis and inhibits proliferation, migration and invasion of pancreatic ductal adenocarcinoma cells
por: Luan, Yun-Peng, et al.
Publicado: (2018)

Molecular drivers and cells of origin in pancreatic ductal adenocarcinoma and pancreatic neuroendocrine carcinoma
por: Gao, He-Li, et al.
Publicado: (2020)

Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma
por: Tong, Yexin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gqratlvlgo5p9pd82i45bpkghn